We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
-4.75%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$384M
AUM Growth
-$38.3M
Cap. Flow
-$13.7M
Cap. Flow %
-3.58%
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
–
Reduced
–
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$12.3M
2
LITS
Lite Strategy Inc
LITS
+$1.39M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$261M 67.96%
2,021,738
– –
GKOS icon
2
Glaukos
GKOS
$8.69B
$33.6M 8.75%
1,018,362
– –
HIND
3
Vyome Holdings
HIND
$14M
– –
0
– –
MGNX icon
4
MacroGenics
MGNX
$241M
$19.9M 5.17%
1,074,316
– –
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$17.6M 4.58%
53,320
– –
CDTX
6
DELISTED
Cidara Therapeutics
CDTX
$11M 2.86%
67,841
– –
IVTY
7
DELISTED
Invuity, Inc
IVTY
$9.61M 2.5%
1,080,272
– –
AGTC
8
DELISTED
Applied Genetic Technologies Corporation
AGTC
$5.75M 1.5%
1,455,904
– –
KALV
9
DELISTED
KalVista Pharmaceuticals
KALV
$2.22M 0.58%
329,942
– –
XENE icon
10
Xenon Pharmaceuticals
XENE
$6.29B
$24K 0.01%
8,293
– –
LITS
11
Lite Strategy Inc
LITS
$33.1M
– –
-29,020
Closed -$1.39M
PRTK
12
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-512,366
Closed -$12.3M

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q3 2017 Portfolio in Review

As of Q3 2017, InterWest Venture Management held 12 positions worth $384M, down 9.1% from $422M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

InterWest Venture Management withdrew a net $13.7M in Q3 2017, closing 2 positions. Its most notable exit was Paratek Pharmaceuticals, Inc., an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • InterWest Venture Management fully exited Paratek Pharmaceuticals, Inc. in Q3 2017, selling an estimated $12.3M.
  • InterWest Venture Management's ten largest holdings make up 100% of its $384M portfolio in Q3 2017.
  • InterWest Venture Management opened 0 new positions and closed 2 in Q3 2017.
  • InterWest Venture Management's portfolio value fell 9.1% quarter-over-quarter to $384M.

Based on InterWest Venture Management's 13F filing for Q3 2017, filed 11 Oct 2017.